Table of Contents Author Guidelines Submit a Manuscript
Journal of Ophthalmology
Volume 2017 (2017), Article ID 4271671, 8 pages
https://doi.org/10.1155/2017/4271671
Clinical Study

The Effect of Perioperative Topical Ketorolac 0.5% on Macular Thickness after Uneventful Phacoemulsification

1Department of Ophthalmology, Erzurum Regional Training and Research Hospital, Erzurum, Turkey
2Department of Ophthalmology, Ankara Ataturk Training and Research Hospital, Faculty of Medicine, Yildirim Beyazit University, Ankara, Turkey
3Department of Ophthalmology, Ulucanlar Eye Training and Research Hospital, Ankara, Turkey
4Department of Ophthalmology, Faculty of Medicine, Hacettepe University, Ankara, Turkey
5Department of Ophthalmology, Malatya Training and Research Hospital, Malatya, Turkey

Correspondence should be addressed to Derya Dal; moc.oohay@ladayred

Received 13 April 2017; Accepted 6 July 2017; Published 23 November 2017

Academic Editor: Terri L. Young

Copyright © 2017 Derya Dal et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Sivaprasad, C. Bunce, and R. Wormald, “Non-steroidal anti-inflammatory agents for cystoid macular oedema following cataract surgery: a systematic review,” British Journal of Ophthalmology, vol. 89, no. 11, pp. 1420–1422, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. G. Gulkilik, S. Kocabora, M. Taskapili, and G. Engin, “Cystoid macular edema after phacoemulsification: risk factors and effect on visual acuity,” Canadian Journal of Ophthalmology, vol. 41, no. 6, pp. 699–703, 2006. View at Publisher · View at Google Scholar
  3. K. Miyake and N. Ibaraki, “Prostaglandins and cystoid macular edema,” Survey of Ophthalmology, vol. 47, pp. 203–218, 2002. View at Publisher · View at Google Scholar · View at Scopus
  4. J. R. Wolter, “The histopathology of cystoid macular edema,” Albrecht von Graefes Archiv für klinische und experimentelle Ophthalmologie, vol. 216, no. 2, pp. 85–101, 1981. View at Google Scholar
  5. P. J. Mc Donnell, Z. C. de la Cruz, and W. R. Green, “Vitreous incarceration complicating cataract surgery. A light and electron microscopic study,” Ophthalmology, vol. 93, no. 2, pp. 247–253, 1986. View at Publisher · View at Google Scholar
  6. J. S. Heier, T. M. Topping, W. Baumann, M. S. Dirks, and S. Chern, “Ketorolac versus prednisolone versus combination therapy in the treatment of acute pseudophakic cystoid macular edema,” Ophthalmology, vol. 107, no. 11, pp. 2034–2038, 2000. View at Publisher · View at Google Scholar · View at Scopus
  7. E. D. Donnenfeld, H. D. Perry, J. R. Wittpenn, R. Solomon, A. Nattis, and T. Chou, “Preoperative ketorolac tromethamine 0.4% in phacoemulsification outcomes: pharmacokinetic-response curve,” Journal of Cataract and Refractive Surgery, vol. 32, no. 9, pp. 1474–1482, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. H. P. Sandoval, L. E. Fernández de Castro, D. T. Vroman, and K. D. Solomon, “A review of the use of ketorolac tromethamine 0.4% in the treatment of post-surgical inflammation following cataract and refractive surgery,” Clinical Ophthalmology, vol. 1, no. 4, pp. 367–371, 2007. View at Google Scholar
  9. T. Yilmaz, M. Cordero-Coma, and M. J. Gallagher, “Ketorolac therapy for the prevention of acute pseudophakic cystoid macular edema: a systematic review,” Eye, vol. 26, no. 2, pp. 252–258, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. J. C. Brown, S. D. Solomon, S. B. Bressler, A. P. Schachat, C. DiBernardo, and N. M. Bressler, “Detection of diabetic foveal edema: contact lens biomicroscopy compared with optical coherence tomography,” Archives of Ophthalmology, vol. 122, no. 3, pp. 330–335, 2004. View at Publisher · View at Google Scholar · View at Scopus
  11. B. Von Jagow, C. Ohrloff, and T. Kohnen, “Macular thickness after uneventful cataract surgery determined by optical coherence tomography,” Graefe's Archive for Clinical and Experimental Ophthalmology, vol. 245, no. 12, pp. 1765–1771, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. J. Mentes, T. Erakgun, F. Afrashi, and G. Kerci, “Incidence of cystoid macular edema after uncomplicated phacoemulsification,” Ophthalmologica, vol. 217, no. 6, pp. 408–412, 2003. View at Publisher · View at Google Scholar · View at Scopus
  13. C. L. Lobo, P. M. Faria, M. A. Soares, R. C. Bernardes, and J. G. Cunha-Vaz, “Macular alterations after small-incision cataract surgery,” Journal of Cataract & Refractive Surgery, vol. 30, no. 4, pp. 752–760, 2004. View at Publisher · View at Google Scholar · View at Scopus
  14. A. J. Flach, “The incidence, pathogenesis and treatment of cystoid macular edema following cataract surgery,” Transactions of the American Ophthalmological Society, vol. 96, pp. 557–634, 1998. View at Google Scholar
  15. P. Massin, E. Vicaut, B. Haouchine, A. Erginay, M. Paques, and A. Gaudric, “Reproducibility of retinal mapping using optical coherence tomography,” Archives of Ophthalmology, vol. 119, no. 8, pp. 1135–1142, 2001. View at Publisher · View at Google Scholar
  16. A. Chan, J. S. Duker, T. H. Ko, J. G. Fujimoto, and J. S. Schuman, “Normal macular thickness measurements in healthy eyes using stratus optical coherence tomography,” Archives of Ophthalmology, vol. 124, no. 2, pp. 193–198, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. L. A. Paunescu, J. S. Schuman, L. L. Price et al., “Reproducibility of nerve fiber thickness, macular thickness, and optic nerve head measurements using StratusOCT,” Investigative Ophthalmology & Visual Science, vol. 45, no. 6, pp. 1716–1724, 2004. View at Publisher · View at Google Scholar · View at Scopus
  18. İ. Perente, C. A. Utine, C. Öztürker et al., “Evaluation of macular changes after uncomplicated phacoemulsification surgery by optical coherence tomography,” Current Eye Research, vol. 32, no. 3, pp. 241–247, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. C. Cagini, T. Fiore, B. Iaccheri, F. Piccinelli, M. A. Ricci, and D. Fruttini, “Macular thickness measured by optical coherence tomography in a healthy population before and after uncomplicated cataract phacoemulsification surgery,” Current Eye Research, vol. 34, no. 12, pp. 1036–1041, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. R. F. Degenring, S. Vey, B. Kamppeter, W. M. Budde, J. B. Jonas, and G. Sauder, “Effect of uncomplicated phacoemulsification on the central retina in diabetic and non-diabetic subjects,” Graefe's Archive for Clinical and Experimental Ophthalmology, vol. 245, no. 1, pp. 18–23, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. S. Asano, K. Miyake, I. Ota et al., “Reducing angiographic cystoid macular edema and blood–aqueous barrier disruption after small-incision phacoemulsification and foldable intraocular lens implantation: multicenter prospective randomized comparison of topical diclofenac 0.1% and betamethasone 0.1%,” Journal of Cataract & Refractive Surgery, vol. 34, no. 1, pp. 57–63, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. K. Miyake, I. Ota, G. Miyake, and J. Numaga, “Nepafenac 0.1% versus fluorometholone 0.1% for preventing cystoid macular edema after cataract surgery,” Journal of Cataract and Refractive Surgery, vol. 37, no. 9, pp. 1581–1588, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. D. R. Almeida, D. Johnson, H. Hollands et al., “Effect of prophylactic nonsteroidal antiinflammatory drugs on cystoid macular edema assessed using optical coherence tomography quantification of total macular volume after cataract surgery,” Journal of Cataract and Refractive Surgery, vol. 34, no. 1, pp. 64–69, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. T. H. Lee, W. Choi, Y. S. Ji, and K. C. Yoon, “Comparison of ketorolac 0.45% versus diclofenac 0.1% for macular thickness and volume after uncomplicated cataract surgery,” Acta Ophthalmologica, vol. 94, pp. 177–182, 2016. View at Publisher · View at Google Scholar · View at Scopus
  25. C. W. Roberts, “Pretreatment with topical didofenac sodium to decrease postoperative inflammation,” Ophthalmology, vol. 103, no. 4, pp. 636–639, 1996. View at Publisher · View at Google Scholar
  26. P. Duan, Y. Liu, and J. Li, “The comparative efficacy and safety of topical non-steroidal anti-inflammatory drugs for the treatment of anterior chamber inflammation after cataract surgery: a systematic review and network meta-analysis,” Graefe's Archive for Clinical and Experimental Ophthalmology, vol. 255, no. 4, pp. 639–649, 2017. View at Publisher · View at Google Scholar
  27. S. M. El-Harazi, R. S. Ruiz, R. M. Feldman, G. Villanueva, and A. Z. Chuang, “Efficacy of preoperative versus postoperative ketorolac tromethamine 0.5% in reducing inflammation after cataract surgery,” Journal of Cataract & Refractive Surgery, vol. 26, no. 11, pp. 1626–1630, 2000. View at Publisher · View at Google Scholar · View at Scopus
  28. F. A. Bucci Jr and L. D. Waterbury, “Aqueous prostaglandin E2 of cataract patients at trough ketorolac and bromfenac levels after 2 days dosing,” Advances in Therapy, vol. 26, pp. 645–650, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. J. S. Heier, C. C. Awh, B. G. Busbee et al., “Vitreous nonsteroidal antiinflammatory drug concentrations and prostaglandin E2 levels in vitrectomy patients treated with ketorolac 0.4%, bromfenac 0.09%, and nepafenac 0.1%,” Retina, vol. 29, no. 9, pp. 1310–1313, 2009. View at Publisher · View at Google Scholar · View at Scopus